Irdai questions Care brass on Esops issue
Mint Mumbai|November 28, 2023
Religare unit asked to reply in a week on "excessive" grant
Anirudh Laskar
Irdai questions Care brass on Esops issue

The insurance regulator has asked top executives of Care Health Insurance Ltd to explain the issue of stock options to non-executive chairperson Rashmi Saluja despite being told not to do so, two people aware of the matter said.

On 22 November, officials of the Insurance Regulatory and Development Authority of India (Irdai) summoned Anuj Gulati and Anoop Singh of Care Health and questioned them about “excessive" stock options issued to Saluja and Gulati, the people said on the condition of anonymity. While Gulati is managing director and chief executive of Care Health, Singh is chief compliance officer.

“Irdai is very concerned about 22.7 million employee stock options (Esops) approved by the Dr. Saluja-led board of Care Health to Dr. Saluja herself. This is worth hundreds of crores of money for one person who is not a promoter, just an employee," one of the two people said.

The issue of stock options came into focus after the Burman family (of Dabur) made an open offer for Religare Enterprises Ltd, the parent of Care Health. After the Religare board opposed the proposal, the Burmans alleged that Saluja, who is also non-executive chairperson of Religare, had received hefty stock options from Care.

The open offer by the Burman family for Religare, where it already owns a 21.54% stake, was announced on 25 September. The offer for the additional 26% at ₹235 per share will cost ₹2,116 crore. The total 51% stake that the Burmans aim to own is worth about ₹3,400 crore. After a brief initial welcome, the Religare board claimed the offer price was low and accused the Burmans of having links with Radha Soami Satsang Beas (RSSB) and Religare founders Shivinder and Malvinder Singh, who are facing fraud charges.

この記事は Mint Mumbai の November 28, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Mint Mumbai の November 28, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

MINT MUMBAIのその他の記事すべて表示
India in economic sweet spot, inflation to moderate: Moody's
Mint Mumbai

India in economic sweet spot, inflation to moderate: Moody's

India's economy is in a sweet spot and its inflation is expected to moderate despite a temporary spurt, Moody's said, projecting optimism about the country's growth prospects despite recent underwhelming data.

time-read
2 分  |
November 16, 2024
Incentive engine to drive modern ships
Mint Mumbai

Incentive engine to drive modern ships

Subsidies for green, high-tech ships under ₹18,000 cr policy

time-read
2 分  |
November 16, 2024
Cement firms wage war on costs as competition soars
Mint Mumbai

Cement firms wage war on costs as competition soars

India's cement makers who once flexed their pricing muscles are caught in a bruising price war, eroding margins at a time of rising demand.

time-read
3 分  |
November 16, 2024
Saudi Arabia doesn’t have enough money for its futuristic city
Mint Mumbai

Saudi Arabia doesn’t have enough money for its futuristic city

The giant futuristic planned city of Neom is proving a headache for Saudi Arabia. Costs are up, schedules are delayed, and in recent days the world’s largest construction project replaced its chief executive of six years.

time-read
4 分  |
November 16, 2024
EV adoption is a marathon, not a sprint: Audi India
Mint Mumbai

EV adoption is a marathon, not a sprint: Audi India

The slowdown in electric vehicle (EV) sales is temporary, and the industry will grow over time, Audi India head Balbir Singh Dhillon said, pointing to the need for extensive charging networks and supportive government policies.

time-read
2 分  |
November 16, 2024
India's trade gap with China soars in Apr-Oct
Mint Mumbai

India's trade gap with China soars in Apr-Oct

The country's green transition increases reliance on Chinese imports

time-read
2 分  |
November 16, 2024
14 nations eye India's generic drug model
Mint Mumbai

14 nations eye India's generic drug model

Countries will specify their requirements, with HLL and MEA coordinating with them for the pharma exports

time-read
1 min  |
November 16, 2024
India urges $1.3 tn annual climate grant
Mint Mumbai

India urges $1.3 tn annual climate grant

Intervening on behalf of like-minded developing countries (LMDCs), India said that developed countries need to commit to provide and mobilise at least $1.3 trillion every year in the New Collective Quantified Goal (NCQG) till 2030.

time-read
2 分  |
November 16, 2024
Over 600 mn cyberattacks daily, AI can secure devices
Mint Mumbai

Over 600 mn cyberattacks daily, AI can secure devices

Microsoft is developing a password-free authentication process to eliminate the risk of breaches

time-read
2 分  |
November 16, 2024
Small businesses ramping up cybersecurity, thanks to AI
Mint Mumbai

Small businesses ramping up cybersecurity, thanks to AI

Rising AI adoption is helping cybersecurity providers hike their marketable base in India

time-read
3 分  |
November 16, 2024